{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:51:54Z","timestamp":1791100314981,"version":"4.1.0"},"reference-count":15,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"DOI":"10.1080\/17425255.2026.2742277","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:54:57Z","timestamp":1790675697000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["How close are we to AI-enabled digital biomarkers in clinical toxicology?"],"prefix":"10.1080","author":[{"given":"Federico","family":"Goodsaid","sequence":"first","affiliation":[{"name":"Regulatory Pathfinders, LLC","place":["Puerto Rico, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,10,3]]},"reference":[{"key":"e_1_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1042\/ETLS20243003"},{"key":"e_1_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-025-00389-8"},{"key":"e_1_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/livers3030032"},{"key":"e_1_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10462-024-11009-5"},{"key":"e_1_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-820077-3.00003-1"},{"key":"e_1_3_3_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/occmed\/kqaf101"},{"key":"e_1_3_3_8_1","unstructured":"FDA proposal on CDER streamlined nonclinical studies and acceptable new approach methodologies (NAMs). [cited 2026 Jul 9]. Available from: https:\/\/www.fda.gov\/about-fda\/center-drug-evaluation-and-research-cder\/cder-streamlined-nonclinical-studies-and-acceptable-new-approach-methodologies-nams and FDA guidance on general considerations for the use of new approach methodologies in drug development. March 2026. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/general-considerations-use-new-approach-methodologies-drug-development."},{"key":"e_1_3_3_9_1","unstructured":"FDA OTP type \u201cC\u201d meetings to discuss new surrogate endpoints. [cited 2026 Jul 9]. Available from: https:\/\/www.fda.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/otp-type-c-meetings-discuss-new-surrogate-endpoints"},{"key":"e_1_3_3_10_1","unstructured":"FDA innovative science and technology approaches for new drugs (ISTAND) program. [cited 2026 Jul 9]. Available from: https:\/\/www.fda.gov\/drugs\/drug-development-tool-ddt-qualification-programs\/innovative-science-and-technology-approaches-new-drugs-istand-program"},{"key":"e_1_3_3_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s43441-025-00889-6"},{"key":"e_1_3_3_12_1","unstructured":"FDA guidance on considerations for the use of artificial intelligence to support regulatory decision-making for drug and biological products. 2025 Jan [cited 2026 Jul 9]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/considerations-use-artificial-intelligence-support-regulatory-decision-making-drug-and-biological"},{"key":"e_1_3_3_13_1","unstructured":"FDA\/EMA regulatory policy on guiding principles of good AI practice in drug development. 2026 Jan [cited 2026 Jul 9]. Available from: https:\/\/www.fda.gov\/about-fda\/artificial-intelligence-drug-development\/guiding-principles-good-ai-practice-drug-development"},{"key":"e_1_3_3_14_1","unstructured":"FDA guidance on M10 bioanalytical method validation and study sample analysis. 2022 Nov [cited 2026 Jul 9]. Available from: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/m10-bioanalytical-method-validation-and-study-sample-analysis"},{"key":"e_1_3_3_15_1","unstructured":"OECD policy on good laboratory practice and compliance monitoring. [cited 2026 Jul 9]. Available from: https:\/\/www.oecd.org\/en\/topics\/sub-issues\/testing-of-chemicals\/good-laboratory-practice-and-compliance-monitoring.html"},{"key":"e_1_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.11.009"}],"container-title":["Expert Opinion on Drug Metabolism & Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425255.2026.2742277","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17425255.2026.2742277","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425255.2026.2742277","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T06:59:13Z","timestamp":1791097153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425255.2026.2742277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,3]]},"references-count":15,"alternative-id":["10.1080\/17425255.2026.2742277"],"URL":"https:\/\/doi.org\/10.1080\/17425255.2026.2742277","relation":{},"ISSN":["1742-5255","1744-7607"],"issn-type":[{"value":"1742-5255","type":"print"},{"value":"1744-7607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iemt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-08-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}